Definitive ablative stereotactic partial breast irradiation in early stage inoperable breast cancer

J Cancer Res Clin Oncol. 2023 Nov;149(17):15553-15559. doi: 10.1007/s00432-023-05053-x. Epub 2023 Aug 31.

Abstract

Purpose: This case series and literature review aims to investigate the efficacy and safety of definitive ablative radiation therapy as a treatment modality for non-operable patients with early stage breast cancer. We present two cases demonstrating the potential of this approach to achieve durable responses.

Methods: We assessed the long-term response of two non-operable patients diagnosed with Stage II (cT2N0M) and Stage IA (T1bN0M0) invasive ductal carcinoma (IDC), who were deemed unfit for surgery due to significant co-morbid conditions. Definitive ablative radiation therapy was administered using stereotactic partial breast irradiation with ablative doses delivered in either a single fraction or two fractions. Serial imaging was conducted to assess treatment response and monitor adverse events.

Results: Both patients exhibited notable treatment responses following definitive ablative radiation therapy. The first patient, an 84-year-old woman, experienced a 69% reduction in tumor size over a follow-up period exceeding 2 years. The second patient, an 87-year-old woman, achieved complete resolution of disease on imaging, with no signs of progression even 26 month post-treatment. Both patients tolerated the treatment well, without significant treatment-related adverse events.

Conclusions: Our case series suggests that definitive ablative radiation therapy may serve as a safe and effective treatment option for non-operable patients with early stage breast cancer. The observed durable treatment responses and minimal toxicity support the potential of this approach. Furthermore, a longer interval between ablative radiation therapy and surgery may enhance treatment response, potentially leading to increased complete pathologic response rates.

Keywords: Breast oncology; Pre-operative breast radiation therapy; Stereotactic ablative radiation (SAbR); Stereotactic body radiation therapy (SBRT); Stereotactic partial breast irradiation (S-PBI).

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Breast Neoplasms* / surgery
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Female
  • Humans
  • Lung Neoplasms* / pathology
  • Radiosurgery* / methods
  • Treatment Outcome